ストックスクリーナーアプリを入手
1.02
0.00%
0.00
アフターアワーズ：
1.02
前日終値:
$1.02
開ける：
$1.0001
24時間の取引高:
64,710
Relative Volume:
0.08
時価総額：
$4.35M
収益：
-
当期純損益:
$-6.78M
株価収益率:
-0.0239
EPS:
-42.6996
ネットキャッシュフロー:
$-4.67M
1週間 パフォーマンス:
+6.23%
1か月 パフォーマンス:
+7.30%
6か月 パフォーマンス:
-27.14%
1年 パフォーマンス:
-14.29%
1日の値動き範囲:
$0.98
$1.04
1週間の範囲:
$0.952
$1.04
52週間の値動き範囲:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
CMND を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.02 | 5.49M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc (CMND) 最新ニュース
Can Clearmind Medicine Inc. rally from current levelsQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Trend analysis for Clearmind Medicine Inc. this weekWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser
How Clearmind Medicine Inc. stock performs during market volatilityIndex Update & Weekly High Return Stock Forecasts - Newser
Institutional scanner results for Clearmind Medicine Inc.Portfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Risk vs reward if holding onto Clearmind Medicine Inc.Weekly Signal Report with Trend Summary - Newser
Why Clearmind Medicine Inc. stock attracts strong analyst attentionBreakout Stocks with Huge Upside - thegnnews.com
Should you wait for a breakout in Clearmind Medicine Inc.Volatility Analysis and Entry Risk Mapping - Newser
Clearmind Medicine Inc. stock trendline breakdownFree Accurate Technical Trend Reversal Picks - Newser
Clearmind Medicine Inc. stock chart pattern explainedDaily Technical Chart Pattern Analysis Report - Newser
Exit strategy if you’re trapped in Clearmind Medicine IncFree Smart Trade Plans With Risk Protection - Newser
What makes Clearmind Medicine Inc. stock price move sharplyFree Reliable Chart-Based Trade Entries - Newser
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - MarketScreener
Clearmind Medicine Inc. stock retracement – recovery analysis5-Year Price Trend Summary and Analysis - Newser
Can a trend reversal in Clearmind Medicine Inc. lead to recoveryEntry Zone Forecast for Momentum Trading - Newser
Short interest data insights for Clearmind Medicine Inc.Entry Confirmation Based on Volatility Analysis - Newser
Can you recover from losses in Clearmind Medicine Inc.Daily Stock Watch Summary with Key Insights - Newser
Will Clearmind Medicine Inc. benefit from macro trendsMomentum-Based Prediction for Quick Returns - Newser
Can volume confirm reversal in Clearmind Medicine Inc.Real Market Tracker with Price Action Tools - Newser
Is it time to cut losses on Clearmind Medicine Inc.Buy List With Technical Entry Triggers - Newser
Published on: 2025-08-09 23:23:05 - Newser
How to use a screener to detect Clearmind Medicine Inc. breakoutsTrend Analysis for Safer Market Entries - Newser
How Clearmind Medicine Inc. stock reacts to Fed policy changesHigh Win Rate Trading Opportunities Detected - metal.it
Clearmind Medicine Inc. stock outlook for YEARTechnical Insight Guide for Safer Trades - Newser
SciSparc-Clearmind collab leads to international patent application - TipRanks
Clearmind announces publication of international patent application under PCT - TipRanks
Clearmind announces patent application for metabolic syndrome treatment - Investing.com
Clearmind announces patent application for metabolic syndrome treatment By Investing.com - Investing.com South Africa
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
Breakthrough Obesity Treatment Patent Targets One-Third of US Adults with Metabolic Syndrome - Stock Titan
Clearmind Medicine Inc (CMND) 財務データ
収益
当期純利益
現金流量
EPS
1.67%
大文字化:
|
ボリューム (24 時間):